5,8,14-Triazatetracyclo 10.3.1.02, 11.04,9 -hexadeca-2 (11), 3,5,7,9-pentane citrate and pharmaceutical composition thereof object

摘要

The present invention is directed to the citrate salt of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene:and pharmaceutical compositions thereof. The present invention is also directed to the various forms of the citrate salt, particularly its hydrate and its anhydrous/nearly anhydrous polymorph. The invention is also directed to processes for preparation of these citrate salt forms.